These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 12511858)

  • 21. Catecholamine metabolism: an update on key biosynthetic enzymes and vesicular monoamine transporters.
    Flatmark T; Almas B; Ziegler MG
    Ann N Y Acad Sci; 2002 Oct; 971():69-75. PubMed ID: 12438092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variations in five genes involved in the excitement of cardiomyocytes.
    Iwasa H; Kurabayashi M; Nagai R; Nakamura Y; Tanaka T
    J Hum Genet; 2001; 46(9):549-52. PubMed ID: 11558906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A molecular glimpse of vesicular monoamine transporters.
    Schuldiner S
    J Neurochem; 1994 Jun; 62(6):2067-78. PubMed ID: 7910628
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of psychostimulants on vesicular monoamine transporter function.
    Fleckenstein AE; Hanson GR
    Eur J Pharmacol; 2003 Oct; 479(1-3):283-9. PubMed ID: 14612158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How did the neurotransmitter cross the bilayer? A closer view.
    Sonders MS; Quick M; Javitch JA
    Curr Opin Neurobiol; 2005 Jun; 15(3):296-304. PubMed ID: 15919190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A chimeric vesicular monoamine transporter dissociates sensitivity to tetrabenazine and unsubstituted aromatic amines.
    Erickson JD
    Adv Pharmacol; 1998; 42():227-32. PubMed ID: 9327885
    [No Abstract]   [Full Text] [Related]  

  • 27. Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transporters.
    Zhang S; Zhen J; Reith ME; Dutta AK
    Bioorg Med Chem; 2004 Dec; 12(23):6301-15. PubMed ID: 15519172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegeneration.
    Truong JG; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2004 May; 492(2-3):143-7. PubMed ID: 15178358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotransmitter transporters in the central nervous system.
    Masson J; Sagné C; Hamon M; El Mestikawy S
    Pharmacol Rev; 1999 Sep; 51(3):439-64. PubMed ID: 10471414
    [No Abstract]   [Full Text] [Related]  

  • 30. Vesicular transporters join the major facilitator superfamily (MFS).
    Linial M
    Trends Biochem Sci; 1993 Jul; 18(7):248-9. PubMed ID: 8212132
    [No Abstract]   [Full Text] [Related]  

  • 31. Protein kinase A affects trafficking of the vesicular monoamine transporters in PC12 cells.
    Yao J; Erickson JD; Hersh LB
    Traffic; 2004 Dec; 5(12):1006-16. PubMed ID: 15522101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ion transport versus gas conduction: function of AMT/Rh-type proteins.
    Ludewig U
    Transfus Clin Biol; 2006; 13(1-2):111-6. PubMed ID: 16563830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
    Wersinger C; Vernier P; Sidhu A
    Biochemistry; 2004 Feb; 43(5):1242-53. PubMed ID: 14756560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The era of ESSTIs is slowly approaching?
    Wyllie MG
    BJU Int; 2005 Jul; 96(1):181-2. PubMed ID: 15963145
    [No Abstract]   [Full Text] [Related]  

  • 35. Purification of vesicular monoamine transporters: from classical techniques to histidine tags.
    Yelin R; Schuldiner S
    Methods Enzymol; 1998; 296():64-72. PubMed ID: 9779440
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain.
    Kilbourn MR; Kemmerer ES; Desmond TJ; Sherman PS; Frey KA
    Exp Neurol; 2004 Aug; 188(2):387-90. PubMed ID: 15246838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters.
    Taylor KM; Morgan HE; Johnson A; Hadley LJ; Nicholson RI
    Biochem J; 2003 Oct; 375(Pt 1):51-9. PubMed ID: 12839489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of long-term biogenic amine transporter blockade on receptor/G-protein coupling in rat brain.
    O'Connor KA; Gregg TC; Davies HM; Childers SR
    Neuropharmacology; 2005 Jan; 48(1):62-71. PubMed ID: 15617728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritoneal macrophages express the serotonin transporter.
    Rudd ML; Nicolas AN; Brown BL; Fischer-Stenger K; Stewart JK
    J Neuroimmunol; 2005 Feb; 159(1-2):113-8. PubMed ID: 15652409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing conformational changes in neurotransmitter transporters: a structural context.
    Goldberg NR; Beuming T; Soyer OS; Goldstein RA; Weinstein H; Javitch JA
    Eur J Pharmacol; 2003 Oct; 479(1-3):3-12. PubMed ID: 14612133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.